Active	Status	Sponsor type	Region	Phase	Filter
2 Active 14 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ledermann, Jonathan A
ICON9, NCT03278717: Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients	Recruiting	3	330	Europe, Canada, RoW	Olaparib, Cediranib	University College, London	Ovarian Cancer	12/23	12/23
NCT01398085 / 2011-000144-21: IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients	Active, not recruiting	2/3	504	Europe	I131 1.1 GBq, Sodium iodide capsule	University College, London, Cancer Research UK	Thyroid Cancer	12/24	03/31
Spiro, Stephen G
No trials found